BPDCN: state of the art
Abstract. The emergence of blastic plasmacytoid dendritic cell neoplasm (BPDCN) as its own distinct entity within the pantheon of hematologic malignancies
Abstract. The emergence of blastic plasmacytoid dendritic cell neoplasm (BPDCN) as its own distinct entity within the pantheon of hematologic malignancies
THURSDAY, Feb. 13, 2025 (HealthDay News) — You may be less likely to develop an especially lethal form of colon cancer if you’re a longtime…
Advancements in comprehending myelodysplastic neoplasms (MDS) have unfolded significantly in recent years, elucidating a myriad of cellular and molecular underpinnings integral to disease progression…
Xenia Parisi, Sanam Loghavi; Acute erythroid leukemia or acute myeloid leukemia with mutated TP53? The battle of phenotype versus genotype. Blood 2025; 145 (7): 784.…
Key PointsAmong patients alive without relapse at dayΒ +100, MRD is uncommon but identifies those at increased risk of relapse and worse survival.Most patie
Mool mantraIk Onkaar(There is one God)Sat Naam(Whose name is Truth)Kartaa Purakh(Is the creator)Nirbh-a-o Nirvair(Has no fear, Has no hate)Akaal Moorat(Is om…
Maternal platelet-activating antiβplatelet factor 4 antibodies led to cerebral venous sinus thrombosis, thrombocytopenia, hyperfibrinolysis, and cerebral bleeding in a neonate.
Shankar Siva: TFS at 1 year is approximately 90% with SABR / cancer, Daniel Heng, OncoDaily, Oncology, SABR, Shankar Siva
CME Symposium Series | March 15-16, 2025, Seattle, Washington All events are complimentary. Both sessions will take place at the Seattle Convention Center 705 Pike…
Patients with metastatic neuroendocrine tumors (NETs) can present with hundreds of lesions, and each lesion might have a unique response pattern to peptide receptor radiopharmaceutical…
MicroabstractWe analyzed vaccination rates and associated outcomes of patients with multiple myelom in the INSIGHT MM study. Influenza vaccination in the prior 2 years and…